Sep 20, 2017 12:00 pm UTC| Business
PITTSBURGH, Sept. 20, 2017 -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other neurocognitive...
Chimerix to Present at Cantor Fitzgerald Global Healthcare Conference
Sep 20, 2017 12:00 pm UTC| Business
DURHAM, N.C., Sept. 20, 2017 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey, M.D., M.P.H., President and Chief...
Charter Financial Announces Metro Atlanta Leadership Team
Sep 20, 2017 12:00 pm UTC| Business
WEST POINT, Ga., Sept. 20, 2017 -- Charter Financial Corporation (NASDAQ:CHFN) (the "Company" or "Charter") announced today its wholly-owned subsidiary, CharterBank (the "Bank"), named its new leadership team throughout...
Arch Therapeutics to Provide Corporate Updates at Upcoming Industry and Investment Conferences
Sep 20, 2017 11:55 am UTC| Business
FRAMINGHAM, Mass., Sept. 20, 2017 -- Terrence Norchi, MD, CEO of Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will present...
Endeavour Launches Construction of Ity CIL Project Based on Optimization Study
Sep 20, 2017 11:47 am UTC| Business
View Funding Sources ...
Ascendant Resources Announces August 2017 Operational Results
Sep 20, 2017 11:30 am UTC| Business
Second consecutive month of positive adjusted EBITDATonnes milled increased to 1,903 tpd, up 9.8% from Q2 average and 53% from January 2017Fleet renewal in-process with new equipment ordered TORONTO, Sept. 20, 2017 --...
Sep 20, 2017 11:30 am UTC| Business
- Actinium is now a member of the ASBMT™ Corporate Council - Two day event focused on facilitating dialogue aimed at advancing the field of bone marrow transplantation and cellular therapy NEW YORK, Sept. 20, 2017 --...